Invention Grant
US09309206B2 Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid
有权
3- [5-（2-氟苯基） - [1,2,4]恶二唑-3-基] - 苯甲酸的结晶形式
![Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid](/docs/US/2016-04-12/US09309206B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid
- Patent Title (中): 3- [5-（2-氟苯基） - [1,2,4]恶二唑-3-基] - 苯甲酸的结晶形式
-
Application No.: US14261774Application Date: 2014-04-25
-
Publication No.: US09309206B2Publication Date: 2016-04-12
- Inventor: Neil G. Almstead , Peter Seongwoo Hwang , Young-Choon Moon
- Applicant: PTC Therapeutics, Inc.
- Applicant Address: US NJ South Plainfield
- Assignee: PTC Therapeutics, Inc.
- Current Assignee: PTC Therapeutics, Inc.
- Current Assignee Address: US NJ South Plainfield
- Agency: Jones Day
- Main IPC: A61K31/41
- IPC: A61K31/41 ; C07D271/06
![Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid](/abs-image/US/2016/04/12/US09309206B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay.
Public/Granted literature
- US20140235679A1 CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID Public/Granted day:2014-08-21
Information query
